Breast cancers with c-MYC knockdown contain more CD3+ and CD8+ T cells, and c-MYC impairs T cell infiltration in vivo, leading to the formation of a “non-inflammatory tumor” microenvironment that induces immune evasion [78]. This evidence concerns the gene MYC and breast cancer.